Our data suggested that Sema4D expression was high in PBMCs of T-ALL, B-ALL, and AML patients, while Sema4D expression in PBMCs of T-ALL patients was even higher than that of B-ALL or AML patients. Here, SEMA4D is linked to acute lymphoblastic leukemia.